CompletedPhase 4

Open-Label Study With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease Psychosis

NCT04292223

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

Movement Disorders Center of Arizona

Scottsdale, Arizona, United States

+17 additional locations

Save this trial

Movement Disorders Center of ArizonaScottsdale, Arizona, United States
Neurology Center of North Orange CountyFullerton, California, United States
Premier Clinical Research Institute, Inc.Miami, Florida, United States
Global Health Research Center, Inc.Miami Lakes, Florida, United States
Quantum Laboratories, Inc.Pompano Beach, Florida, United States
Parkinson's Disease Treatment Center of Southwest FloridaPort Charlotte, Florida, United States
Accel Research Sites - Brain and Spine InstitutePort Orange, Florida, United States
Infinity Clinical Research, LLCSunrise, Florida, United States
Premiere Research Institute at Palm Beach NeurologyWest Palm Beach, Florida, United States
AU Movement and Memory DisordersAugusta, Georgia, United States
Maine Medical Partners NeurologyScarborough, Maine, United States
Wentworth Health Partners Coastal Neurology ServicesDover, New Hampshire, United States
Bio Behavioral HealthToms River, New Jersey, United States
Neurology Diagnostics, Inc.Dayton, Ohio, United States
The Orthopedic FoundationNew Albany, Ohio, United States
Central States ResearchTulsa, Oklahoma, United States
KCA NeurologyFranklin, Tennessee, United States
Neurological Associates of North TexasDallas, Texas, United States